Top

Published in:

01-06-2018 | Original Article - Tumor - Glioma

Psychiatric co-morbidity, distress, and use of psycho-social services in adult glioma patients—a prospective study

Authors: Susanne Singer, Julia Roick, Helge Danker, Rolf-Dieter Kortmann, Kirsten Papsdorf, Sabine Taubenheim, Mirjam Renovanz, Katja Jähne, Jürgen Meixensberger

Published in: Acta Neurochirurgica | Issue 6/2018

Abstract

Background

Distress impacts the daily life of glioma patients. This study explored its course over time and the usage of psychosocial care.

Methods

A consecutive sample of glioma patients completed the Hospital Anxiety and Depression Scale to assess distress levels at admission to the hospital (t1), before discharge (t2), after 3 months (t3), and after 6 months (t4). They were interviewed with the Structured Clinical Interview for DSM-IV to ascertain psychiatric disorders at t2. Psycho-oncological care in the hospital was determined with the Hospital Information System, and the use of outpatient treatment was evaluated with the Health Care Usage Questionnaire at t4. We compared the percentages of elevated distress, psychiatric co-morbidity, and care usage between men and women.

Results

During the study period, 37 patients were enrolled. Nineteen percent of the patients were diagnosed with a psychiatric disorder. The percentages of patients with elevated distress were 56, 59, 39, and 40% at t1, t2, t3, and t4, respectively. Participants who did not survive the 6 months presented with higher levels of distress. In the hospital, 14% of those with elevated distress were visited by a psycho-oncologist. In the outpatient setting, 43% of those with elevated distress visited a neuro-psychiatrist, and 14% went to a psychotherapist. There was no evidence for an effect of gender on psychiatric co-morbidity, distress, or care use.

Conclusions

A significant proportion of glioma patients report elevated distress during the hospital stay and thereafter. Only a fraction of them receive mental health care.

Aaronson N, Ahmedzai S, Bergmann B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, de Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F, for the EORTC Study Group on Quality of Life (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed

Aaronson NK, Taphoorn MJB, Heimans JJ, Postma TJ, Gundy CM, Beute GN, Slotman BJ, Klein M (2011) Compromised health-related quality of life in patients with low-grade Glioma. J Clin Oncol 29:4430–4435CrossRefPubMed

Boele FW, van Uden-Kraan CF, Hilverda K, Reijneveld JC, Cleijne W, Klein M, Verdonck-de Leeuw IM (2016) Attitudes and preferences toward monitoring symptoms, distress, and quality of life in glioma patients and their informal caregivers. Support Care Cancer 24:3011–3022PubMedPubMedCentral

Borooah VK (2010) Gender differences in the incidence of depression and anxiety: econometric evidence from the USA. J Happiness Stud 11:663–682CrossRef

Brebach R, Sharpe L, Costa DSJ, Rhodes P, Butow P (2016) Psychological intervention targeting distress for cancer patients: a meta-analytic study investigating uptake and adherence. Psychooncology 25:882–890CrossRefPubMed

Briest S, Papsdorf K, Köhler U, Krauß O, Singer S (2015) Sind Brustkrebspatientinnen mit frühen Stadien weniger psychisch belastet als jene mit fortgeschrittenen Stadien? Onkologe 21:245–249CrossRef

DAngelo C, Mirijello A, Leggio L, Ferrulli A, Carotenuto V, Icolaro N, Miceli A, D'Angelo V, Gasbarrini G, Addolorato G (2008) State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1-year longitudinal study. J Neurosurg 108:281–286CrossRef

Dirven L, Reijneveld JC, Taphoorn MJB (2014) Health-related quality of life or quantity of life: a difficult trade-off in primary brain tumors? Semin Oncol 41:541–552CrossRefPubMed

Efficace F, Taphoorn M (2012) Methodological issues in designing and reporting health-related quality of life in cancer clinical trials: the challenge of brain cancer studies. J Neuro-Oncol 108:221–226CrossRef

10.

Erharter A, Giesinger J, Kemmler G, Schauer-Maurer G, Stockhammer G, Muigg A, Hutterer M, Rumpold G, Sperner-Unterweger B, Holzner B (2010) Implementation of computer-based quality-of-life monitoring in brain tumor outpatients in routine clinical practice. J Pain Symptom Manag 39:219–229CrossRef

11.

First M, Spitzer R, Gibbon M, Williams J (1997) Structured clinical interview for DSM-IV Axis I disorders (SCID-I), clinician version. American Psychiatric Press, Washington, DC

12.

Ford E, Catt S, Chalmers A, Fallowfield L (2012) Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro-Oncology 14:392–404CrossRefPubMedPubMedCentral

13.

Geue K, Richter R, Buttstädt M, Brähler E, Böhler U, Singer S (2012) Art therapy in psycho-oncology - recruitment of participants and gender differences in usage. Support Care Cancer 20:679–686CrossRefPubMed

14.

Glaesmer H, Brahler E, Martin A, Mewes R, Rief W (2008) Gender differences in subjective help seeking threshold and health care utilization: is there an interrelation between both features? Int J Psychol 43:438

15.

Goebel S, Strenge H, Mehdorn HM (2012) Acute stress in patients with brain cancer during primary care. Support Care Cancer 20:1425–1434CrossRefPubMed

16.

Goebel S, von Harscher M, Mehdorn HM (2011) Comorbid mental disorders and psychosocial distress in patients with brain tumours and their spouses in the early treatment phase. Support Care Cancer 19:1797–1805CrossRefPubMed

17.

Grassi L, Watson M, on behalf of the IPOS Federation of Psycho-Oncology Societies' co-authors (2012) Psychosocial care in cancer: an overview of psychosocial programmes and national cancer plans of countries within the International Federation of Psycho-Oncology Societies. Psycho-Oncology 21:1027–1033CrossRefPubMed

18.

Hickmann AK, Nadji-Ohl M, Haug M, Hopf N, Ganslandt O, Giese A, Renovanz M (2016) Suicidal ideation, depression, and health-related quality of life in patients with benign and malignant brain tumors: a prospective observational study in 83 patients. Acta Neurochir 158:1669–1682CrossRefPubMed

19.

Johnson M, Stone GL (1989) Logic and nurture - gender differences in thinking about psychotherapy. Prof Psychol Res Pract 20:123–127CrossRef

20.

Khan F, Amatya B (2013) Factors associated with long-term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour. J Neuro-Oncol 111:355–366CrossRef

21.

Kvale EA, Murthy R, Taylor R, Lee JY, Nabors LB (2009) Distress and quality of life in primary high-grade brain tumor patients. Support Care Cancer 17:793–799CrossRefPubMed

22.

Lin L, Chiang HH, Acquaye AA, Vera-Bolanos E, Gilbert MR, Armstrong TS (2013) Uncertainty, mood states, and symptom distress in patients with primary brain tumors: analysis of a conceptual model using structural equation modeling. Cancer 119:2796–2806CrossRefPubMed

23.

Litofsky NS, Farace E, Anderson F, Meyers CA, Huang W, Laws ER (2004) Depression in patients with high-grade glioma: results of the glioma outcomes project. Neurosurgery 54:358–366CrossRefPubMed

24.

Lyons Z, Janca A (2009) Diagnosis of male depression does general practitioner gender play a part? Aust Fam Physician 38:743–746PubMed

25.

Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P (2006) Gender difference in relation to depression and quality of life among patients with a primary brain tumor. Eur Psychiatry 21:194–199CrossRefPubMed

26.

Mehnert A, Brähler E, Faller H, Härter M, Keller M, Schulz H, Wegscheider K, Weis J, Boehncke A, Hund B, Reuter K, Richard M, Sehner S, Sommerfeldt S, Szalai C, Wittchen HU, Koch U (2014) Four-week prevalence of mental disorders in cancer patients across major tumor entitites. J Clin Oncol 32:3540–3546CrossRefPubMed

27.

Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12:160–174CrossRefPubMed

28.

Mitchell AJ, Symonds P (2013) Implementation of distress screening by Cancer clinicians during routine clinical care. Part I. Focus on efficiency and acceptability of frontline screening. Psychooncology 22:91

29.

Pelletier G, Verhoef MJ, Khatri N, Hagen N (2002) Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neuro-Oncol 57:41–49CrossRef

30.

Piil K, Jakobsen J, Christensen KB, Juhler M, Jarden M (2015) Health-related quality of life in patients with high-grade gliomas: a quantitative longitudinal study. J Neuro-Oncol 124:185–195CrossRef

31.

Renovanz M, Hickmann A-K, Coburger J, Kohlmann K, Janko M, Reuter AK, Keric N, Gutenberg A, Nadji-Ohl M, König J, Singer S, Giese A, Hechtner M (2017) Assessing psychological and supportive care needs in Glioma patients – feasibility study on the use of the supportive care needs survey short form (SCNS-SF34-G) and the supportive care needs survey screening tool (SCNS-ST9) in clinical practice. Eur J Cancer Care. https://doi.org/10.1111/ecc.12598

32.

Robin AM, Walbert T, Mikkelsen T, Kalkanis SN, Rock J, Lee I, Rosenblum ML (2014) Through the patient's eyes: the value of a comprehensive brain tumor center. J Neuro-Oncol 119:465–472CrossRef

33.

Rooney AG, Carson A, Grant R (2011) Depression in cerebral Glioma patients: a systematic review of observational studies. J Natl Cancer Inst 103:61–76CrossRefPubMed

34.

Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, Grant R (2011) Frequency, clinical associations, and longitudinal course of major depressive disorder in adults with cerebral Glioma. J Clin Oncol 29:4307–4312CrossRefPubMed

35.

Rooney AG, McNamara S, MacKinnon M, Fraser M, Rampling R, Carson A, Grant R (2013) The frequency, longitudinal course, clinical associations, and causes of emotional distress during primary treatment of cerebral glioma. Neuro-Oncology 15:635–643CrossRefPubMedPubMedCentral

36.

Rooney AG, van Nieuwenhuizen D, Reijneveld JC, Grant R (2009) Female gender is not a proven risk factor for depression in glioma. J Neuro-Oncol 95:449CrossRef

37.

Rosenblum ML, Kalkanis S, Goldberg W, Rock J, Mikkelsen T, Remer S, Whitehouse S, Nerenz D (2009) Odyssey of hope: a physician's guide to communicating with brain tumor patients across the continuum of care. J Neuro-Oncol 92:241–251CrossRef

38.

Scaratti C, Leonardi M, Saladino A, Anghileri E, Broggi M, Lamperti E, Fariselli L, Ayadi R, Tringali G, Schiavolin S (2017) Needs of neuro-oncological patients and their caregivers during the hospitalization and after discharge: results from a longitudinal study. Support Care Cancer 25:2137–2145CrossRefPubMed

39.

Singer S, Bringmann H, Hauss J, Kortmann R-D, Köhler U, Krauß O, Schwarz R (2007) Häufigkeit psychischer Begleiterkrankungen und der Wunsch nach psychosozialer Unterstützung bei Tumorpatienten im Akutkrankenhaus. Dtsch Med Wochenschr 132:2071–2076CrossRefPubMed

40.

Singer S, Das-Munshi J, Brähler E (2010) Prevalence of mental health conditions in cancer patients in acute care – a meta-analysis. Ann Oncol 21:925–930CrossRefPubMed

41.

Singer S, Hohlfeld S, Müller-Briel D, Dietz A, Brähler E, Schröter K, Lehmann-Laue A (2011) Psychosoziale Versorgung von Krebspatienten - Versorgungsdichte und -bedarf. Psychotherapeut 56:386–393CrossRef

42.

Singer S, Kuhnt S, Götze H, Hauss J, Hinz A, Liebmann A, Krauß O, Lehmann A, Schwarz R (2009) Hospital anxiety and depression scale cut-off scores for Cancer patients in acute care. Br J Cancer 100:908–912CrossRefPubMedPubMedCentral

43.

Tang PL, Wang HH, Chou FH (2015) A systematic review and meta-analysis of demoralization and depression in patients with Cancer. Psychosomatics 56:634–643CrossRefPubMed

44.

Taphoorn MJB, Sizoo EM, Bottomley A (2010) Review on quality of life issues in patients with primary brain tumors. Oncologist 15:618–626CrossRefPubMedPubMedCentral

45.

Thode N, Bergmann E, Kamtsiuris P, Kurth M (2005) Einflussfaktoren auf die ambulante Inanspruchnahme in Deutschland. Bundesgesundheitsblatt 48:296–306CrossRef

46.

Velikova G, Coens C, Efficace F, Greimel E, Groenvold M, Johnson C, Singer S, van de Poll-Franse L, Young T, Bottomley A, on behalf of the EORTC Quality of Life Group (2012) Health-related quality of life in EORTC clinical trials - 30 years of progress from methodological developments to making a real impact on oncology practice. Eur J Cancer Suppl 10:141–149CrossRef

47.

Warrington TP, Bostwick JM (2006) Psychiatric adverse effects of corticosteroids. Mayo Clin Proc 81:1361–1367CrossRefPubMed

48.

Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, Fratiglioni L, Jennum P, Lieb R, Maercker A, van Os J, Preisig M, Salvador-Carulla L, Simon R, Steinhausen HC (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21:655–679CrossRefPubMed

49.

Zeissig SR, Singer S, Koch L, Zeeb H, Merbach M, Bertram H, Eberle A, Schmid-Höpfner S, Holleczek B, Waldmann A, Arndt V (2015) Utilisation of psychosocial and informational services in immigrant and non-immigrant German cancer survivors. Psycho-Oncology 24:919–925CrossRefPubMed

50.

Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370CrossRefPubMed

Title: Psychiatric co-morbidity, distress, and use of psycho-social services in adult glioma patients—a prospective study
Authors: Susanne Singer
Julia Roick
Helge Danker
Rolf-Dieter Kortmann
Kirsten Papsdorf
Sabine Taubenheim
Mirjam Renovanz
Katja Jähne
Jürgen Meixensberger
Publication date: 01-06-2018
Publisher: Springer Vienna
Published in: Acta Neurochirurgica / Issue 6/2018
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-018-3527-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Psychiatric co-morbidity, distress, and use of psycho-social services in adult glioma patients—a prospective study

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2018

Decompressive craniectomy in traumatic brain injury—the discussion must continue

Systemic inflammatory response in pediatric central nervous system tumors

Neck pain and proprioception deficit influence the cervical motion assessed by instantaneous axis of rotation

Ultrasound-guided brain surgery: echographic visibility of different pathologies and surgical applications in neurosurgical routine

Surgical treatment of a gauzoma with associated obliterative arteriopathy and review of the literature

Correlation between the severity of myelopathy and cervical morphometric parameters on dynamic magnetic resonance imaging